Mediator kinase inhibition reverses castration resistance of advanced prostate cancer

J Li, TA Hilimire, Y Liu, L Wang, J Liang… - The Journal of …, 2024 - Am Soc Clin Investig
Mediator kinases CDK19 and CDK8, pleiotropic regulators of transcriptional reprogramming,
are differentially regulated by androgen signaling, but both kinases are upregulated in …

Kinase Drug Discovery: Impact of Open Science and Artificial Intelligence

F Miljković, J Bajorath - Molecular Pharmaceutics, 2024 - ACS Publications
Given their central role in signal transduction, protein kinases (PKs) were first implicated in
cancer development, caused by aberrant intracellular signaling events. Since then, PKs …

Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies

X Yin, Z He, K Chen, K Ouyang, C Yang, J Li… - Frontiers in …, 2024 - frontiersin.org
CDK8 is an important member of the cyclin-dependent kinase family associated with
transcription and acts as a key “molecular switch” in the Mediator complex. CDK8 regulates …

Preclinical therapeutic efficacy of RAF/MEK/ERK and IGF1R/AKT/mTOR inhibition in Neuroblastoma

S Stauffer, JS Roth, ER Hernandez, JT Kowalczyk… - Cancers, 2024 - mdpi.com
Simple Summary The prognosis for patients with relapsed neuroblastoma is poor, and novel
treatment options for these patients are needed. Some relapsed neuroblastoma tumors …

Mediator kinase inhibitors suppress triple-negative breast cancer growth and extend tumor suppression by mTOR and AKT inhibitors

X Ding, J Liang, AC Sharko, TA Hilimire, J Li… - Proceedings of the …, 2024 - pnas.org
Triple-negative breast cancers (TNBC) are treated primarily by chemotherapy and lack
clinically validated therapeutic targets. In particular, inhibitors of the PI3K/AKT/mTOR …

Integrating multi-omics data reveals neuroblastoma subtypes in the tumor microenvironment

J Fan, S Tang, X Kong, Y Cun - Life Sciences, 2024 - Elsevier
Neuroblastoma (NB) is a severe pediatric tumor originating from the developing sympathetic
nervous system, characterized by diverse clinical outcomes, including spontaneous …

CDK19 and CDK8 Mediator kinases drive androgen-independent in vivo growth of castration-resistant prostate cancer

J Li, TA Hilimire, Y Liu, L Wang, J Liang, B Gyorffy… - Biorxiv, 2023 - biorxiv.org
Castration-resistant prostate cancer (CRPC) remains incurable due to its high plasticity. We
found that Mediator kinases CDK8 and CDK19, pleiotropic regulators of transcriptional …

Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes

EK Kokinos, SA Tsymbal, AV Galochkina… - Viruses, 2023 - mdpi.com
Hyperactivation of the immune system remains a dramatic, life-threatening complication of
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …

CRISPR-Cas System Is an Effective Tool for Identifying Drug Combinations That Provide Synergistic Therapeutic Potential in Cancers

Y Kim, HM Lee - Cells, 2023 - mdpi.com
Despite numerous efforts, the therapeutic advancement for neuroblastoma and other cancer
treatments is still ongoing due to multiple challenges, such as the increasing prevalence of …

[PDF][PDF] Inhibition of Cyclin-Dependent Kinases 8/19 Restricts Bacterial and Virus-Induced Inflammatory Responses in Monocytes. Viruses 2023, 15, 1292

EK Kokinos, SA Tsymbal, AV Galochkina… - 2023 - academia.edu
Hyperactivation of the immune system remains a dramatic, life-threatening complication of
viral and bacterial infections, particularly during pneumonia. Therapeutic approaches to …